New strategy aims to stop pancreatic cancer from coming back
NCT ID NCT07044453
Summary
This study is testing a new, personalized approach to chemotherapy for people with pancreatic cancer who have had surgery. After initial chemotherapy and surgery, doctors will look at how much cancer is left and assign patients to one of two different follow-up chemotherapy plans. The goal is to see if matching the follow-up treatment to the patient's specific situation can better prevent the cancer from returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTED PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU de Rouen
RECRUITINGRouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.